The negative side effects of opioid-based narcotics underscore the search for alternative non-opioid bioactive compounds that act on the peripheral nervous system to avoid central nervous system-mediated side effects. The transient receptor potential V1 ion [...]
Even without specific opioid prescription guidelines for cancer patients, UC Davis Comprehensive Cancer Center uses various pain treatment strategies, ranging from blocking nerves and stimulating the spinal cord to injecting steroids and prescribing new drugs [...]
Researchers at Boston Children's Hospital have developed a novel way to deliver neurotoxin called tetrodotoxin (TTX) as a painkiller, and they have turned up some positive results from rat studies.Full story.
Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain. CNTX-0290, [...]
Facing an urgent need for safer and more effective therapies for those suffering from debilitating pain, Saint Louis University researchers are on a mission to find a non-narcotic off-switch for pain. Full story.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources | Powered by Insight Marketing Group
American Academy of Pain (AAMP) is a nonprofit, 501(c)(6) tax-exempt organization.
